Search Results 451-460 of 5847 for albumin
... . VID-20127976. Home; Brightcove-Brachial Plexus Injury Patient Story-Single. Have 2X the impact! Give Today. The deadline to have twice the impact to ...
This study aims to identify serological and other blood biomarkers to aid in identificaiton of diagnosis and mechanistic understanding of autoimmune disorders.
The aim of this project is to evaluate whether kidney biopsy tissue will stain positive for C3d under immunofluorescence in patients who had renal thrombotic ...
... . VID-20132102. Home; Brightcove-Multiple Sclerosis-Overview-RightChannel. Have 2X the impact! Give Today. Make a gift that can go twice as far to ...
Look up information about prescription drugs, over-the-counter medications, herbs, vitamins and supplements.
The purpose of this study is to create a data collection and bioregistry of blood samples from Mayo Clinic patients with amyloidosis, suspected amyloidosis, and ...
Serum albumin ≥ 3.0 g/dL;; INR ≤ 1.5. Participants receiving oral anticoagulants may be enrolled with an INR < 2. Participants with other causes of INR ...
High levels of rheumatoid factor in the blood are most often related to autoimmune diseases, such as rheumatoid arthritis and Sjogren syndrome. But rheumatoid ...
... albumin > 3.0 g/dL. Adequate renal function: Serum creatinine clearance CLcr > 30 mL/min). Adequate coagulation function: International Normalized Ratio or ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.